Novel Approach To Drug Insolubility Strengthens PolyTherics Patent Estate Polytherics Ltd ("PolyTherics"), a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy that specialises in the targeted application of polymers to biopharmaceuticals, announced the grant of a European patent on the application of polymer complexation technology to improve drug efficacy.
Source: www.medicalnewstoday.comMental Illness In England Cost 50 Billion Pounds In 2007, UK A major year-long study into the cost of meeting the mental
health needs of the nation over the next two decades is published today by the King's Fund. Paying the Price suggests that significant investment in evidence-based services could help thousands back to productive work. The report reveals that mental illness in England cost £50 billion in 2007. Almost half, £22.
Source: www.medicalnewstoday.com1 Small Step For A Lab Science, 1 Green Leap For Mankind "Environmentally friendly" is not a phrase normally used to describe a chemistry lab. But thanks to a groundbreaking discovery at Tel Aviv University, the chemical industry is a step closer to being green.Prof. Arkadi Vigalok from the School of Chemistry at Tel Aviv University has discovered a way to use water to make certain steps of a complicated chain of chemical reactions more environmentally-friendly.Prof.
Source: www.medicalnewstoday.comBureaucracy Has Delayed Plans For Three FDA Offices In China, HHS Secretary Leavitt Says HHS Secretary Mike Leavitt on Friday said that Chinese bureaucracy has delayed plans to establish FDA offices in three cities -- Beijing, Shanghai and Guangzhou -- that would monitor exports of food, medications, medical devices and other consumer products to the U.S., the
Source: www.medicalnewstoday.comNew Society Award For Medicines Safety, UK Plans for a new
medicines safety award were announced by Hemant Patel, President of the Royal Pharmaceutical Society of Great Britain's President at the Society's AGM on 21 May. The annual award will be presented to those that have demonstrated a significant contributionto improving
medicines safety in Great Britain. Documented benefits for patients that have been achieved, and which could be rolled out more widely, will also form part of the selection criteria.
Source: www.medicalnewstoday.comBrand-Name Prescription Drug Companies Reached 14 Deals With Generic Manufacturers To Delay Sale Of Generic Medications In FY 2007, FTC Report Finds Brand-name
prescription drug makers in fiscal year 2007 reached 14 agreements with generic drug makers to delay market entry of generic medications, according to a report released on Wednesday by the Federal Trade Commission, Reuters reports (Bartz, Reuters, 5/23).
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 9:00 PM
